Table 7. Odds ratio and 95% confidence intervals for the association between dietary acidity with RA and its clinical symptoms.
Variable | PRAL Median | p value* | Median NEAP | p value* | Median DAL | p value* | ||||
---|---|---|---|---|---|---|---|---|---|---|
PRAL < −7.64 | PRAL > −7.64 | NEAP < 44.80 | NEAP > 44.80 | DAL < 33.19 | DAL > 33.19 | |||||
Joint pain | ||||||||||
Crude Model | 1 | 0.60 (0.40–1.06) | 0.09 | 1 | 0.83 (0.52–1.35) | 0.47 | 1 | 0.74 (0.45–1.19) | 0.20 | |
Model 1 | 1 | 0.72 (0.43–1.10) | 0.20 | 1 | 1.00 (0.60–1.67) | 0.97 | 1 | 0.99 (0.59–1.67) | 1.00 | |
Model 2 | 1 | 0.70 (0.46–1.28) | 0.32 | 1 | 0.99 (0.59–1.65) | 0.98 | 1 | 0.99 (0.58–1.68) | 0.98 | |
Model 3 | 1 | 0.70 (0.46–1.29) | 0.30 | 1 | 1.00 (0.60–1.67) | 0.99 | 1 | 0.99 (0.58–1.69) | 0.90 | |
Joint stiffness | ||||||||||
Crude Model | 1 | 1.03 (0.52–2.00) | 0.93 | 1 | 1.10 (0.56–2.14) | 0.76 | 1 | 1.12 (0.57–2.19) | 0.72 | |
Model 1 | 1 | 1.13 (0.57–2.23) | 0.72 | 1 | 1.28 (0.64–2.54) | 0.47 | 1 | 1.44 (0.72–2.89) | 0.29 | |
Model 2 | 1 | 1.19 (0.59–2.37) | 0.60 | 1 | 1.31 (0.66–2.62) | 0.43 | 1 | 1.33 (0.72–2.89) | 0.42 | |
Model 3 | 1 | 1.18 (0.59–2.36) | 0.60 | 1 | 1.32 (0.66–2.64) | 0.42 | 1 | 1.32 (0.65–2.68) | 0.43 | |
RA | ||||||||||
Crude Model | 1 | 1.16 (0.62–2.10) | 0.62 | 1 | 1.07 (0.56–2.04) | 0.83 | 1 | 1.01 (0.54–1.80) | 0.97 | |
Model 1 | 1 | 1.31 (0.67–2.50) | 0.42 | 1 | 1.27 (0.62–2.50) | 0.50 | 1 | 1.45 (0.74–2.80) | 0.27 | |
Model 2 | 1 | 1.38 (0.70–2.72) | 0.35 | 1 | 1.47 (0.69–3.10) | 0.31 | 1 | 1.56 (0.78–3.10) | 0.20 | |
Model 3 | 1 | 1.39 (0.70–2.76) | 0.34 | 1 | 1.48 (0.69–3.10) | 0.30 | 1 | 1.58 (0.79–3.10) | 0.19 |
Model 1: adjusted for age, sex; Model 2: adjusted for age, sex, socioeconomic status and smoking status; and Model 3: adjusted for age, sex, socioeconomic status, smoking status and dietary energy intake.
RA, rheumatoid arthritis; PRAL, potential renal acid load; NEAP, net endogenous acid production; DAL, dietary acid load.
*Calculated by logistic regression.